Quality by design based UPLC method development and validation for simultaneous estimation of albuterol and budesonide in pharmaceutical dosage forms
International Journal of Drug Delivery Technology · 13.04.2026 · 16 (9s)
DOI: 10.25258/ijddt.16.9s.18 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 13.04.2026. Verfasst von T. Mallika und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The combination of albuterol and budesonide is used to prevent and treat asthma, breathing problems, tightness in the chest, coughing, wheezing, and shortness of breath in adults. In the current work, a QBD based UPLC method was developed and verified for the assessment of Albuterol and budesonide in the pharmaceutical dosage form. A CHS column (100 nm × 2.1 mm × 1.7 µm) was employed containing a mobile phase that includes acetonitrile and a 7.8 g solution of NaHPO₄ in a 66.4:33.6 (v/v) ratio. At 0.3 mL/min, the flow rate was kept constant, and the optimized detection wavelength was set at 240.0 nm. The retention times for Albuterol and Budesonide were observed at 1.180 minutes and 1.657 minutes, accordingly. The technique was proved following the ICH Q2 guidelines confirming its reliability. For accuracy and intermediate precision, the relative standard deviation (RSD) studies of Albuterol and Budesonide was within 2.0%. The accuracy for quantification ranged from 99.08% to 99.90%, utilizing a regression coefficient exceeding 0.999. The research results indicate that developed Albuterol and budesonide UPLC method can be employed for formulation evaluation and clinical studies.
Zitieren
APA
Mallika, T., & Aparna, P. (2026). Quality by design based UPLC method development and validation for simultaneous estimation of albuterol and budesonide in pharmaceutical dosage forms. International Journal of Drug Delivery Technology, 16(9s). https://doi.org/10.25258/ijddt.16.9s.18
Vancouver
Mallika T, Aparna P. Quality by design based UPLC method development and validation for simultaneous estimation of albuterol and budesonide in pharmaceutical dosage forms. International Journal of Drug Delivery Technology. 2026;16(9s). doi:10.25258/ijddt.16.9s.18
BibTeX
@article{Mallika2026,
author = {Mallika, T. and Aparna, P.},
title = {Quality by design based UPLC method development and validation for simultaneous estimation of albuterol and budesonide in pharmaceutical dosage forms},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {9s},
doi = {10.25258/ijddt.16.9s.18}
}
EUVIMED